Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control

Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction

1999 • 873 citations

Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes

1995 • 861 citations

Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease

2000 • 791 citations

In Vivo Formation of 8-Iso-Prostaglandin F _2α and Platelet Activation in Diabetes Mellitus

1999 • 753 citations

NIDDM and Its Metabolic Control Predict Coronary Heart Disease in Elderly Subjects

1994 • 564 citations

Hematology: Basic Principles and Practice

1995 • 526 citations

A revised model of platelet aggregation

2000 • 349 citations

Mechanisms Determining Course and Outcome of Diabetic Patients Who Have Had Acute Myocardial Infarction

1997 • 301 citations

RELATIONSHIP OF CLINICAL DIABETES AND ASYMPTOMATIC HYPERGLYCEMIA TO RISK OF CORONARY HEART DISEASE MORTALITY IN MEN AND WOMEN

1986 • 295 citations

5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.

1990 • 291 citations

Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience

1996 • 281 citations

The Origin of P-selectin as a Circulating Plasma Protein

1997 • 250 citations

Local Inhibition of Tissue Factor Reduces the Thrombogenicity of Disrupted Human Atherosclerotic Plaques

1999 • 233 citations

Role of Cardiovascular Risk Factors in Prevention and Treatment of Macrovascular Disease in Diabetes

1989 • 233 citations

Long-Term Glycemic Control Relates to Mortality in Type II Diabetes

1995 • 227 citations

Hyperglycemia-Induced Thrombin Formation in Diabetes: The Possible Role of Oxidative Stress

1995 • 184 citations

Diabetes and Cardiovascular Disease

2021 • 123 citations

Vascular Thrombosis in Type II Diabetes Mellitus

1993 • 102 citations

Effect of Advanced Glycation End Product–Modified Albumin on Tissue Factor Expression by Monocytes

1997 • 79 citations

Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.

1998 • 77 citations

Plasma β-Thromboglobulin, Platelet Factor 4, Fibrinopeptide A, and Other Hemostatic Functions During Improved, Short-Term Glycemic Control in Diabetes Mellitus

1984 • 61 citations

Haemostatic Abnormalities Persist Despite Glycaemic Improvement by Insulin Therapy in Lean Type 2 Diabetic Patients

1994 • 49 citations

Increased thrombus formation relates to ambient blood glucose and leukocyte count in diabetes mellitus type 2

2000 • 49 citations

Improved glycemic control and platelet function abnormalities in diabetic patients with microvascular disease

2000 • 25 citations

Cardiovascular disease in type 2 diabetes.

1999 • 17 citations

Antithrombin III activity, von Willebrand factor antigen and platelet function in young diabetic patients treated with multiple insulin injections versus insulin pump treatment

1989 • 7 citations

Antithrombin III activity, von Willebrand factor antigen and platelet function in young diabetic patients treated with multiple insulin injections versus insulin pump treatment

1989 • 3 citations

Cited By (0)

Loading...